We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

EACVI 螢幕截圖

關於EACVI

最新EACVI建議和專家共識論文。

The EACVI Recommendations App developed by the European Association of Cardiovascular Imaging (EACVI) provides clear and easy to follow abridged versions of the latest EACVI Recommendations and Expert Consensus papers.

The App is designed to help professionals using non invasive cardiovascular imaging in their daily practice. It includes tables, figures, reference values and calculators and a link to the full recommendation papers published in our journal the European Heart Journal – Cardiovascular Imaging (EHJ-CI) by EACVI experts.

Some recommendations are available in different languages.

Included recommendations:

The App includes 8 abridged recommendations, 4 of which are available in French, Chinese and Portuguese:

• Multimodality imaging in pericardial disease (2014)

• Recommendations for Transoesophageal Echocardiography: 2014 update (2014)

• Complications of Radiotherapy in Adults (2013)

• Transcatheter Interventions (2011)

• Aortic and pulmonary regurgitation - Valvular regurgitation (2010)

• Mitral and tricuspid regurgitation - Valvular regurgitation (2010)

• Echocardiography in infective endocarditis (2010)

• Diastolic Function (2009)

Included calculators / algorithms / reference value tables:

• PISA (Mitral Regurgitation)

• EuroSCORE (External)

• STS Mortality Score (External)

• Estimation of filling Pressures (Diastolic Function)

• Practical approach to grade diastolic dysfunction

• Clinical suspicion of IE

• Patient management after chest radiotherapy

最新版本1.1.0更新日誌

Last updated on 2017年12月16日

• New Abridged Recommendation: Arrhythmogenic Cardiomyopathy

翻譯中...

更多應用信息

最新版本

請求 EACVI 更新 1.1.0

上傳者

DeAndre D Hill

系統要求

Android 4.1+

更多
訂閱APKPure
第一時間獲取熱門安卓遊戲應用的首發體驗,最新資訊和玩法教程。
不,謝謝
訂閱
訂閱成功!
您已訂閱APKPure。
訂閱APKPure
第一時間獲取熱門安卓遊戲應用的首發體驗,最新資訊和玩法教程。
不,謝謝
訂閱
成功!
您已訂閱我們的郵件通知。